Wingspan Technology released eTMF 2.1
Wingspan Technology released eTMF 2.1, which builds upon eTMF 2.0, a major update released in April 2014 featuring a commercial-style user interface (UI) and user dashboards. This latest version features integrated scanning capabilities that eliminate the need for manual upload or indexing.
Wingspan eTMF 2.1 provides a streamlined process for high volume scanning of TMF documents by providing printable transmittals that are then attached to documents for scanning. The eTMF uses information from the transmittals to automatically attach metadata to the scanned documents. Once scanned, documents and metadata are released directly into a final Quality Control process.
Read the full release here.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.